Saisei Ventures
Jonathan Yeh is a Managing Partner at Saisei Ventures, a venture capital firm focused on early-stage companies aiming to enhance health outcomes. Additionally, Jonathan is the Co-Founder & Board Observer at Kenai Therapeutics, which specializes in iPSC-based cell replacement therapy for neurological diseases like Parkinson's Disease. Previously, Jonathan held positions at 株式会社ヘリオス, CCRM, IRICoR, and the Leucegene Project, showcasing their expertise in investments, business development, and project leadership. With a strong academic background, including a PhD in Experimental Medicine from McGill University, Jonathan is well-equipped for their role in the healthcare and biotechnology sectors.
This person is not in any teams
This person is not in any offices
Saisei Ventures
Saisei Ventures is a leading venture capital firm focused on growing and harnessing the Japanese biotech ecosystem; a region rich in opportunities and potential. We create ventures that start from bold ideas and empower dynamic entrepreneurs by filling in technical, operational, or financial gaps. Our approach combines Western expertise and Japanese innovation to build globally competitive companies that will have the greatest impact on patient lives.